Flow Cytometry for Clinical Applications: Recommendations on Assay Transfer and Method Validation
Spotlight on Immuno-Oncology and Dermatology
Date: July 1, 2022
Duration: 51 Minutes
Topics covered:
-
Advantages of sample testing reproducibility among different laboratories for a more successful transition to clinical settings
-
Considerations for choosing the right technologies used in cell-based assay development approaches: example of receptor occupancy (RO) measurement by flow cytometry
-
The process toward intra-laboratory assay transfer and overcoming the challenges of standardization/harmonization in flow cytometry
-
Points to consider in analytical procedures and method validation for clinical studies
Register to Watch Webinar On Demand
Deborah Phippard PhD
Precision for Medicine
Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
Laura Lozza PhD
Precision for Medicine
Laura has long-standing expertise in immune monitoring and immune assay development with a particular focus on flow cytometry assays. Her focused on human immunology, including characterizing the regulatory activities of CD4 T cells, as well as analyzing the response of human dendritic cells in tuberculosis disease and BCG vaccination.